Cargando…

Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity

The aim of this study was to identify the differences in terms of demographics, socioeconomic status and overall levels of morbidity-related health burden between population strata characterized by high levels of adherence to American Diabetes Association screening guidelines and their low-adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Yashkin, Arseniy, Akushevich, Igor, Yashin, Anatoliy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740805/
http://dx.doi.org/10.1093/geroni/igaa057.725
_version_ 1783623616823296000
author Yashkin, Arseniy
Akushevich, Igor
Yashin, Anatoliy
author_facet Yashkin, Arseniy
Akushevich, Igor
Yashin, Anatoliy
author_sort Yashkin, Arseniy
collection PubMed
description The aim of this study was to identify the differences in terms of demographics, socioeconomic status and overall levels of morbidity-related health burden between population strata characterized by high levels of adherence to American Diabetes Association screening guidelines and their low-adherence counterparts. Factor analysis was used to create a single continuous measure of adherence which was stratified and analyzed using the Cox proportional hazards model to identify adherence levels associated with protective effects for mortality. Based on the results, the entire population of Health and Retirement Study respondents newly diagnosed with diabetes mellitus, type II was then stratified into four levels of adherence – excellent, sufficient, insufficient, poor – based on the strength of the protective effect associated with that level of the adherence factor and compared. Mortality in the group associated with excellent adherence was 41 to 57 percentage points lower than among their counterparts. High levels of adherence were associated with White and Hispanic race, low morbidity burden, high education and economic status, and low levels of functioning limitations. Based on race-specific survival function estimates we found that the life expectancy at age 65 of an individual newly diagnosed with type II diabetes mellitus could be improved from 14.97 to 19.64 years for whites, 13.36 to 19.58 years for African Americans and 14.92 to 21.28 for Hispanics if average adherence levels are increased to the highest levels observed in our study. Finally, we found that adherence levels were improving over the 1991-2015 period suggesting successful diabetes awareness efforts.
format Online
Article
Text
id pubmed-7740805
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77408052020-12-21 Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity Yashkin, Arseniy Akushevich, Igor Yashin, Anatoliy Innov Aging Abstracts The aim of this study was to identify the differences in terms of demographics, socioeconomic status and overall levels of morbidity-related health burden between population strata characterized by high levels of adherence to American Diabetes Association screening guidelines and their low-adherence counterparts. Factor analysis was used to create a single continuous measure of adherence which was stratified and analyzed using the Cox proportional hazards model to identify adherence levels associated with protective effects for mortality. Based on the results, the entire population of Health and Retirement Study respondents newly diagnosed with diabetes mellitus, type II was then stratified into four levels of adherence – excellent, sufficient, insufficient, poor – based on the strength of the protective effect associated with that level of the adherence factor and compared. Mortality in the group associated with excellent adherence was 41 to 57 percentage points lower than among their counterparts. High levels of adherence were associated with White and Hispanic race, low morbidity burden, high education and economic status, and low levels of functioning limitations. Based on race-specific survival function estimates we found that the life expectancy at age 65 of an individual newly diagnosed with type II diabetes mellitus could be improved from 14.97 to 19.64 years for whites, 13.36 to 19.58 years for African Americans and 14.92 to 21.28 for Hispanics if average adherence levels are increased to the highest levels observed in our study. Finally, we found that adherence levels were improving over the 1991-2015 period suggesting successful diabetes awareness efforts. Oxford University Press 2020-12-16 /pmc/articles/PMC7740805/ http://dx.doi.org/10.1093/geroni/igaa057.725 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Yashkin, Arseniy
Akushevich, Igor
Yashin, Anatoliy
Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity
title Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity
title_full Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity
title_fullStr Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity
title_full_unstemmed Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity
title_short Determinants of Adherence to ADA Type II Diabetes Mellitus Guidelines: Implications for Longevity
title_sort determinants of adherence to ada type ii diabetes mellitus guidelines: implications for longevity
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740805/
http://dx.doi.org/10.1093/geroni/igaa057.725
work_keys_str_mv AT yashkinarseniy determinantsofadherencetoadatypeiidiabetesmellitusguidelinesimplicationsforlongevity
AT akushevichigor determinantsofadherencetoadatypeiidiabetesmellitusguidelinesimplicationsforlongevity
AT yashinanatoliy determinantsofadherencetoadatypeiidiabetesmellitusguidelinesimplicationsforlongevity